Skip to main content
. 2013 Oct 16;13:146. doi: 10.1186/1471-2377-13-146

Figure 1.

Figure 1

Prevalence of cutaneous adverse events per DMT as reported by dermatologists (black bars), by patients themselves (white bars), and by the treating neurologists (grey bars).

HHS Vulnerability Disclosure